Anaheim, Calif.—The leading cause of death in breast cancer patients today is heart disease. Women in their 40s and 50s are experiencing heart failure and other cardiotoxicities after treatment with radiation, anthracyclines and HER2 receptor antagonists, noted Sandra Cuellar, PharmD, BCOP, at the 13th Annual Conference of the Hematology/Oncology Pharmacy Association.
“It’s no longer that they are diagnosed with breast cancer and they are dying of breast